Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02612337 · ClinicalTrials.gov registry record · Phase 3
Study of OTO-104 in Subjects With Unilateral Meniere's Disease
A Phase 3 study, sponsored by Otonomy.
- Completed
- Registry status
- Phase 3
- Development phase
- 166
- Enrollment target
NCT02612337 is a Phase 3 study that has completed, run by Otonomy. The registered enrollment target is 166 participants.
The verdict
NCT02612337, a Phase 3 study, has completed, sponsored by Otonomy.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 166 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease.
Interventions
- DRUG Placebo
- DRUG OTO-104
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2015-10-27 |
| Est. Completion | 2017-07-18 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02612337
The ClinicalTrials.gov registry entry for NCT02612337 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Otonomy, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02612337 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02612337 about?
NCT02612337 is a clinical study titled "Study of OTO-104 in Subjects With Unilateral Meniere's Disease". The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease.
What is the current status of trial NCT02612337?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 166 participants. The study started on 2015-10-27. Estimated completion is 2017-07-18.
What interventions are being tested in trial NCT02612337?
The interventions under investigation include: Placebo (DRUG), OTO-104 (DRUG).
Who is sponsoring clinical trial NCT02612337?
This trial is sponsored by Otonomy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.